Your browser doesn't support javascript.
loading
In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial" by A Dietrich et al.
Dietrich, Antje; Andreeff, Michael; Koi, Lydia; Bergmann, Ralf; Schubert, Maik; Schreiner, Lena; Löck, Steffen; Sihver, Wiebke; Freudenberg, Robert; Hering, Sandra; Pietzsch, Hans-Jürgen; Steinbach, Jörg; Kotzerke, Jörg; Baumann, Michael; Krause, Mechthild.
Afiliação
  • Dietrich A; German Cancer Consortium (DKTK), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, G
  • Andreeff M; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Germany.
  • Koi L; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, T
  • Bergmann R; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Schubert M; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Schreiner L; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, Germany.
  • Löck S; German Cancer Consortium (DKTK), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sihver W; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Freudenberg R; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Germany.
  • Hering S; Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
  • Pietzsch HJ; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • Steinbach J; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany; Institute for Legal Medicine, Faculty of Medicine Carl Gustav Carus, TU, Dresden, Germany.
  • Kotzerke J; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Germany; Department of Chemistry and Food Chemistry, TU, Dresden, Germany.
  • Baumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Facul
  • Krause M; German Cancer Consortium (DKTK), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, G
Radiother Oncol ; 161: 261-262, 2021 08.
Article em En | MEDLINE | ID: mdl-34119587
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) Idioma: En Ano de publicação: 2021 Tipo de documento: Article